carisoprodol
Generic: carisoprodol
Labeler: asclemed usa, inc.Drug Facts
Product Profile
Brand Name
carisoprodol
Generic Name
carisoprodol
Labeler
asclemed usa, inc.
Dosage Form
TABLET
Routes
Active Ingredients
carisoprodol 250 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
76420-852
Product ID
76420-852_21e58fc9-d824-4d1d-e063-6294a90a2acc
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA040792
DEA Schedule
civ
Listing Expiration
2026-12-31
Marketing Start
2016-11-08
Pharmacologic Class
Established (EPC)
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
76420852
Hyphenated Format
76420-852
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
carisoprodol (source: ndc)
Generic Name
carisoprodol (source: ndc)
Application Number
ANDA040792 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 250 mg/1
Packaging
- 100 TABLET in 1 BOTTLE (76420-852-01)
- 30 TABLET in 1 BOTTLE (76420-852-30)
- 60 TABLET in 1 BOTTLE (76420-852-60)
- 90 TABLET in 1 BOTTLE (76420-852-90)
Packages (4)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "21e58fc9-d824-4d1d-e063-6294a90a2acc", "openfda": {"nui": ["N0000175730", "N0000175737"], "unii": ["21925K482H"], "rxcui": ["197446", "730794"], "spl_set_id": ["301f5e6a-54e1-4885-b9cb-de475de59b22"], "pharm_class_pe": ["Centrally-mediated Muscle Relaxation [PE]"], "pharm_class_epc": ["Muscle Relaxant [EPC]"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (76420-852-01)", "package_ndc": "76420-852-01", "marketing_start_date": "20240912"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (76420-852-30)", "package_ndc": "76420-852-30", "marketing_start_date": "20240912"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (76420-852-60)", "package_ndc": "76420-852-60", "marketing_start_date": "20240912"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (76420-852-90)", "package_ndc": "76420-852-90", "marketing_start_date": "20240912"}], "brand_name": "carisoprodol", "product_id": "76420-852_21e58fc9-d824-4d1d-e063-6294a90a2acc", "dosage_form": "TABLET", "pharm_class": ["Centrally-mediated Muscle Relaxation [PE]", "Muscle Relaxant [EPC]"], "product_ndc": "76420-852", "dea_schedule": "CIV", "generic_name": "carisoprodol", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "carisoprodol", "active_ingredients": [{"name": "CARISOPRODOL", "strength": "250 mg/1"}], "application_number": "ANDA040792", "marketing_category": "ANDA", "marketing_start_date": "20161108", "listing_expiration_date": "20261231"}